Horizon Investments LLC lifted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 1.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,716 shares of the financial services provider’s stock after purchasing an additional 121 shares during the quarter. Horizon Investments LLC’s holdings in CME Group were worth $1,560,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Avidian Wealth Enterprises LLC lifted its stake in shares of CME Group by 2.6% in the 4th quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock valued at $411,000 after purchasing an additional 45 shares during the last quarter. TFC Financial Management Inc. lifted its position in CME Group by 8.4% in the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider’s stock worth $137,000 after buying an additional 46 shares during the last quarter. Waldron Private Wealth LLC boosted its stake in CME Group by 2.0% during the fourth quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider’s stock worth $549,000 after buying an additional 47 shares during the period. Venturi Wealth Management LLC boosted its stake in CME Group by 12.1% during the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider’s stock worth $101,000 after buying an additional 47 shares during the period. Finally, First Affirmative Financial Network raised its stake in shares of CME Group by 2.3% in the fourth quarter. First Affirmative Financial Network now owns 2,141 shares of the financial services provider’s stock valued at $497,000 after acquiring an additional 49 shares during the period. Institutional investors own 87.75% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on CME shares. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a research note on Monday. Morgan Stanley boosted their target price on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Royal Bank of Canada increased their price target on CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a report on Thursday, February 13th. Oppenheimer boosted their price objective on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Finally, Barclays increased their target price on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $238.93.
CME Group Stock Performance
Shares of NASDAQ:CME opened at $265.47 on Thursday. The firm has a 50 day moving average of $245.07 and a 200 day moving average of $233.51. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $95.66 billion, a price-to-earnings ratio of 27.45, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $267.91.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a $1.25 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.88%. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is currently 51.71%.
CME Group announced that its Board of Directors has authorized a share buyback program on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its shares are undervalued.
Insider Transactions at CME Group
In other CME Group news, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 27,076 shares of company stock valued at $6,871,496 in the last 90 days. Insiders own 0.30% of the company’s stock.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Should You Invest in Penny Stocks?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- High Flyers: 3 Natural Gas Stocks for March 2022
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.